Cardiovascular Business Week
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cardiovascular Business Week
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Brigham & Women's Hospital
Utility of drug-eluting stents reviewed
December 7th, 2004
The utility of drug-eluting stents in the treatment of cardiovascular disease has been reviewed. "Current treatment options for acute coronary syndromes as well as chronic stable angina often include the use of percutaneous coronary intervention (PCI) with routine stenting," scientists in the United States explained. "The clear benefits of stents have lead to their routine use for prevention of restenosis." "However, the benefits of stenting demonstrated on some aspects of restenosis are compromised by the induction of restenosis by neointimal hyperplasia that is stimulated by standard bare metal stents," noted S.A. Baroletti and colleagues at the...
Source: Cardiovascular Business Week (2004-12-07)
|
